SummitTX Capital’s Chemours CC Stock Holding History

SummitTX Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-152,938	Closed	-$3.37M	–	810
2026 Q1	$3.37M	Buy	+152,938	New	+$2.66M	0.11%	220

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

SummitTX Capital's CC Position: Q2 2026 in Review

SummitTX Capital sold out of Chemours (CC) in Q2 2026, closing a stake of 152,938 shares — an estimated $3.37M sold.

SummitTX Capital first reported a position in CC in Q1 2026 and held it in 1 quarter. The position peaked at $3.37M in Q1 2026. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

SummitTX Capital reported no remaining Chemours position as of Q2 2026 after selling out during the quarter.
SummitTX Capital sold 152,938 Chemours shares in Q2 2026, an estimated $3.37M.
SummitTX Capital first reported a position in Chemours in Q1 2026 and held it in 1 quarter.
SummitTX Capital's Chemours position peaked at $3.37M in Q1 2026.
469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.